Product
Imipenem + Cilastatin
Aliases
XNW4107, Imipenem/Cilastatin
3 clinical trials
3 indications
Indication
Bacterial InfectionsIndication
Complicated Urinary Tract InfectionIndication
Acute PyelonephritisClinical trial
A PHASE 1, OPEN-LABEL STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF XNW4107, IMIPENEM AND CILASTATIN ADMINISTERED CONCURRENTLY AS INTRAVENOUS INFUSION TO SUBJECTS WITH VARIOUS DEGREES OF RENAL FUNCTIONStatus: Completed, Estimated PCD: 2021-10-30
Clinical trial
A Phase 1, Open-label Study to Evaluate the Safety and Intrapulmonary Pharmacokinetics of XNW4107, Imipenem and Cilastatin in Healthy SubjectsStatus: Completed, Estimated PCD: 2021-05-15
Clinical trial
A Multi-center, Randomized, Double-blind, Active Controlled, Parallel Groups, Phase II Study to Evaluate the Efficacy and Safety of Intravenous HRS-8427 in the Treatment of Adults With Complicate Urinary Tract Infection, Including Acute PyelonephritisStatus: Not yet recruiting, Estimated PCD: 2024-06-01